This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Sep 21;37(36):2740-2742.

doi: 10.1093/eurheartj/ehw360.

The evolving field of cardio-oncology: beyond anthracyclines and heart failure

Michael G Fradley¹

Affiliations

Affiliation

¹ Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, USA; and Cardio-Oncology ProgramH. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA mfradley@health.usf.edu.

PMID: 27694540
DOI: 10.1093/eurheartj/ehw360

The evolving field of cardio-oncology: beyond anthracyclines and heart failure

Michael G Fradley. Eur Heart J. 2016.

. 2016 Sep 21;37(36):2740-2742.

doi: 10.1093/eurheartj/ehw360.

Author

Michael G Fradley¹

Affiliation

¹ Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, USA; and Cardio-Oncology ProgramH. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA mfradley@health.usf.edu.

PMID: 27694540
DOI: 10.1093/eurheartj/ehw360

No abstract available

PubMed Disclaimer

Similar articles

Heart failure and chemotherapeutic agents.
Piper S, McDonagh T. Piper S, et al. Future Cardiol. 2015 Jul;11(4):453-70. doi: 10.2217/fca.15.28. Epub 2015 Aug 3. Future Cardiol. 2015. PMID: 26234158 Review.
Cardio-oncology: cardiovascular complications of cancer therapy.
Henning RJ, Harbison RD. Henning RJ, et al. Future Cardiol. 2017 Jul;13(4):379-396. doi: 10.2217/fca-2016-0081. Epub 2017 Jun 29. Future Cardiol. 2017. PMID: 28660778 Review.
Cardio-Oncology-Beyond Anthracyclines and Ejection Fraction.
Geenty PD, Gregory AT, Nolan M, Denniss AR, Pepe S, Sverdlov AL, Thomas L. Geenty PD, et al. Heart Lung Circ. 2024 May;33(5):547-552. doi: 10.1016/j.hlc.2024.05.002. Heart Lung Circ. 2024. PMID: 38823894 No abstract available.
Incidence, time of occurrence and response to heart failure therapy in patients with anthracycline cardiotoxicity.
Khan AA, Ashraf A, Singh R, Rahim A, Rostom W, Hussain M, Renner I, Collins NJ. Khan AA, et al. Intern Med J. 2017 Jan;47(1):104-109. doi: 10.1111/imj.13305. Intern Med J. 2017. PMID: 27800661
Cardio-oncology: Understanding cardiotoxicity to guide patient focused imaging.
Russell R 3rd. Russell R 3rd. J Nucl Cardiol. 2018 Dec;25(6):2159-2167. doi: 10.1007/s12350-018-01470-5. Epub 2018 Nov 15. J Nucl Cardiol. 2018. PMID: 30443750 Review.

See all similar articles

Cited by

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients with Cancer Undergoing Chemotherapy.
Vaduganathan M, Hirji SA, Qamar A, Bajaj N, Gupta A, Zaha V, Chandra A, Haykowsky M, Ky B, Moslehi J, Nohria A, Butler J, Pandey A. Vaduganathan M, et al. JACC CardioOncol. 2019 Sep;1(1):54-65. doi: 10.1016/j.jaccao.2019.08.006. Epub 2019 Sep 24. JACC CardioOncol. 2019. PMID: 33083790 Free PMC article.
Multimodality imaging in the assessment of bone marrow-derived mesenchymal stem cell therapy for doxorubicin-induced cardiomyopathy.
Qu C, Wang J, Wang Y, He F, Shi X, Zhang Z, Wang Y. Qu C, et al. Am J Cancer Res. 2022 Feb 15;12(2):574-584. eCollection 2022. Am J Cancer Res. 2022. PMID: 35261788 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations